Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $8.91M in the twelve months ending March 31, 2024, with 3.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.83M with 10,240.54% year-over-year growth. In the year 2023, Verrica Pharmaceuticals had annual revenue of $5.12M, a decrease of -43.27%.

• Revenue (ttm): $8.91M
• Revenue Growth: +3.18%
• P/S Ratio: 35.55
• Revenue / Employee: $89,130
• Employees: 100
• Market Cap: 316.88M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.